nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Irinotecan—hematologic cancer	0.1	1	CbGbCtD
Gallamine Triethiodide—Headache—Thalidomide—hematologic cancer	0.000173	0.000224	CcSEcCtD
Gallamine Triethiodide—Pain—Prednisolone—hematologic cancer	0.000173	0.000224	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—hematologic cancer	0.000173	0.000224	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—hematologic cancer	0.000172	0.000223	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—hematologic cancer	0.00017	0.00022	CcSEcCtD
Gallamine Triethiodide—Nausea—Thiotepa—hematologic cancer	0.000169	0.000219	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000169	0.000219	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—hematologic cancer	0.000169	0.000219	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mitoxantrone—hematologic cancer	0.000169	0.000218	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irinotecan—hematologic cancer	0.000169	0.000218	CcSEcCtD
Gallamine Triethiodide—Vomiting—Carmustine—hematologic cancer	0.000169	0.000218	CcSEcCtD
Gallamine Triethiodide—Rash—Carmustine—hematologic cancer	0.000167	0.000216	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Carmustine—hematologic cancer	0.000167	0.000216	CcSEcCtD
Gallamine Triethiodide—Vomiting—Alitretinoin—hematologic cancer	0.000167	0.000216	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Triamcinolone—hematologic cancer	0.000167	0.000216	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisolone—hematologic cancer	0.000167	0.000216	CcSEcCtD
Gallamine Triethiodide—Anaemia—Prednisone—hematologic cancer	0.000166	0.000215	CcSEcCtD
Gallamine Triethiodide—Headache—Carmustine—hematologic cancer	0.000166	0.000215	CcSEcCtD
Gallamine Triethiodide—Rash—Alitretinoin—hematologic cancer	0.000166	0.000214	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Alitretinoin—hematologic cancer	0.000165	0.000214	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Betamethasone—hematologic cancer	0.000165	0.000214	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000165	0.000214	CcSEcCtD
Gallamine Triethiodide—Vomiting—Ifosfamide—hematologic cancer	0.000165	0.000214	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Cisplatin—hematologic cancer	0.000165	0.000213	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Dexamethasone—hematologic cancer	0.000165	0.000213	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Betamethasone—hematologic cancer	0.000165	0.000213	CcSEcCtD
Gallamine Triethiodide—Headache—Alitretinoin—hematologic cancer	0.000165	0.000213	CcSEcCtD
Gallamine Triethiodide—Angioedema—Prednisone—hematologic cancer	0.000164	0.000213	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—hematologic cancer	0.000164	0.000213	CcSEcCtD
Gallamine Triethiodide—Nausea—Thalidomide—hematologic cancer	0.000164	0.000212	CcSEcCtD
Gallamine Triethiodide—Rash—Ifosfamide—hematologic cancer	0.000164	0.000212	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Ifosfamide—hematologic cancer	0.000163	0.000212	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—hematologic cancer	0.000163	0.000211	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—hematologic cancer	0.000163	0.00021	CcSEcCtD
Gallamine Triethiodide—Malaise—Prednisone—hematologic cancer	0.000162	0.00021	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—hematologic cancer	0.000162	0.00021	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—hematologic cancer	0.000162	0.00021	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—hematologic cancer	0.000162	0.00021	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—hematologic cancer	0.000162	0.000209	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—hematologic cancer	0.000161	0.000209	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—hematologic cancer	0.000161	0.000208	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vincristine—hematologic cancer	0.000161	0.000208	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisolone—hematologic cancer	0.000161	0.000208	CcSEcCtD
Gallamine Triethiodide—Asthenia—Cisplatin—hematologic cancer	0.000161	0.000208	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—hematologic cancer	0.00016	0.000208	CcSEcCtD
Gallamine Triethiodide—Fatigue—Triamcinolone—hematologic cancer	0.00016	0.000207	CcSEcCtD
Gallamine Triethiodide—Rash—Vincristine—hematologic cancer	0.00016	0.000207	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vincristine—hematologic cancer	0.000159	0.000206	CcSEcCtD
Gallamine Triethiodide—Pain—Triamcinolone—hematologic cancer	0.000159	0.000206	CcSEcCtD
Gallamine Triethiodide—Headache—Vincristine—hematologic cancer	0.000159	0.000205	CcSEcCtD
Gallamine Triethiodide—Nausea—Carmustine—hematologic cancer	0.000157	0.000204	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mitoxantrone—hematologic cancer	0.000157	0.000203	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irinotecan—hematologic cancer	0.000157	0.000203	CcSEcCtD
Gallamine Triethiodide—Nausea—Alitretinoin—hematologic cancer	0.000156	0.000202	CcSEcCtD
Gallamine Triethiodide—Rash—Irinotecan—hematologic cancer	0.000155	0.000201	CcSEcCtD
Gallamine Triethiodide—Rash—Mitoxantrone—hematologic cancer	0.000155	0.000201	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irinotecan—hematologic cancer	0.000155	0.000201	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mitoxantrone—hematologic cancer	0.000155	0.000201	CcSEcCtD
Gallamine Triethiodide—Headache—Mitoxantrone—hematologic cancer	0.000154	0.0002	CcSEcCtD
Gallamine Triethiodide—Headache—Irinotecan—hematologic cancer	0.000154	0.0002	CcSEcCtD
Gallamine Triethiodide—Nausea—Ifosfamide—hematologic cancer	0.000154	0.0002	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000154	0.000199	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000154	0.000199	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Prednisone—hematologic cancer	0.000153	0.000198	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Triamcinolone—hematologic cancer	0.000153	0.000198	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Cisplatin—hematologic cancer	0.000153	0.000198	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—hematologic cancer	0.000153	0.000198	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000152	0.000197	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Dexamethasone—hematologic cancer	0.000151	0.000196	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Betamethasone—hematologic cancer	0.000151	0.000196	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—hematologic cancer	0.000151	0.000196	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—hematologic cancer	0.000151	0.000196	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—hematologic cancer	0.000151	0.000196	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—hematologic cancer	0.000151	0.000195	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—hematologic cancer	0.00015	0.000195	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—hematologic cancer	0.00015	0.000195	CcSEcCtD
Gallamine Triethiodide—Nausea—Vincristine—hematologic cancer	0.00015	0.000195	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—hematologic cancer	0.00015	0.000194	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—hematologic cancer	0.00015	0.000194	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—hematologic cancer	0.00015	0.000194	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisolone—hematologic cancer	0.000149	0.000193	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000149	0.000193	CcSEcCtD
Gallamine Triethiodide—Urticaria—Triamcinolone—hematologic cancer	0.000148	0.000191	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—hematologic cancer	0.000147	0.000191	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—hematologic cancer	0.000147	0.00019	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Triamcinolone—hematologic cancer	0.000147	0.00019	CcSEcCtD
Gallamine Triethiodide—Nausea—Mitoxantrone—hematologic cancer	0.000146	0.000189	CcSEcCtD
Gallamine Triethiodide—Nausea—Irinotecan—hematologic cancer	0.000146	0.000189	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000146	0.000189	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000146	0.000189	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dexamethasone—hematologic cancer	0.000145	0.000188	CcSEcCtD
Gallamine Triethiodide—Fatigue—Betamethasone—hematologic cancer	0.000145	0.000188	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—hematologic cancer	0.000145	0.000188	CcSEcCtD
Gallamine Triethiodide—Pain—Dexamethasone—hematologic cancer	0.000144	0.000187	CcSEcCtD
Gallamine Triethiodide—Pain—Betamethasone—hematologic cancer	0.000144	0.000187	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Prednisone—hematologic cancer	0.000143	0.000186	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Prednisone—hematologic cancer	0.000143	0.000185	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—hematologic cancer	0.000143	0.000185	CcSEcCtD
Gallamine Triethiodide—Vomiting—Cisplatin—hematologic cancer	0.000142	0.000184	CcSEcCtD
Gallamine Triethiodide—Rash—Cisplatin—hematologic cancer	0.000141	0.000183	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Cisplatin—hematologic cancer	0.000141	0.000182	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—hematologic cancer	0.00014	0.000182	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—hematologic cancer	0.00014	0.000181	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—hematologic cancer	0.000139	0.00018	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dexamethasone—hematologic cancer	0.000139	0.00018	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Betamethasone—hematologic cancer	0.000139	0.00018	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—hematologic cancer	0.000139	0.00018	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—hematologic cancer	0.000138	0.000178	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Triamcinolone—hematologic cancer	0.000137	0.000177	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—hematologic cancer	0.000136	0.000176	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—hematologic cancer	0.000135	0.000174	CcSEcCtD
Gallamine Triethiodide—Urticaria—Betamethasone—hematologic cancer	0.000134	0.000173	CcSEcCtD
Gallamine Triethiodide—Urticaria—Dexamethasone—hematologic cancer	0.000134	0.000173	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Prednisone—hematologic cancer	0.000134	0.000173	CcSEcCtD
Gallamine Triethiodide—Asthenia—Triamcinolone—hematologic cancer	0.000133	0.000173	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dexamethasone—hematologic cancer	0.000133	0.000173	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dexamethasone—hematologic cancer	0.000133	0.000173	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Betamethasone—hematologic cancer	0.000133	0.000173	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Betamethasone—hematologic cancer	0.000133	0.000173	CcSEcCtD
Gallamine Triethiodide—Nausea—Cisplatin—hematologic cancer	0.000133	0.000172	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Prednisone—hematologic cancer	0.000132	0.000171	CcSEcCtD
Gallamine Triethiodide—Pruritus—Triamcinolone—hematologic cancer	0.000132	0.00017	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—hematologic cancer	0.000131	0.00017	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—hematologic cancer	0.00013	0.000169	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—hematologic cancer	0.00013	0.000168	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—hematologic cancer	0.000129	0.000167	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—hematologic cancer	0.000129	0.000167	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—hematologic cancer	0.000128	0.000166	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—hematologic cancer	0.000128	0.000166	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—hematologic cancer	0.000128	0.000166	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—hematologic cancer	0.000128	0.000165	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisolone—hematologic cancer	0.000127	0.000165	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisolone—hematologic cancer	0.000127	0.000165	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000127	0.000165	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—hematologic cancer	0.000127	0.000164	CcSEcCtD
Gallamine Triethiodide—Fatigue—Prednisone—hematologic cancer	0.000127	0.000164	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisolone—hematologic cancer	0.000127	0.000164	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—hematologic cancer	0.000126	0.000163	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—hematologic cancer	0.000124	0.00016	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—hematologic cancer	0.000123	0.000159	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—hematologic cancer	0.000122	0.000158	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Prednisone—hematologic cancer	0.000121	0.000157	CcSEcCtD
Gallamine Triethiodide—Asthenia—Betamethasone—hematologic cancer	0.000121	0.000157	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dexamethasone—hematologic cancer	0.000121	0.000157	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—hematologic cancer	0.00012	0.000156	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—hematologic cancer	0.00012	0.000156	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisolone—hematologic cancer	0.00012	0.000155	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—hematologic cancer	0.00012	0.000155	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—hematologic cancer	0.00012	0.000155	CcSEcCtD
Gallamine Triethiodide—Pruritus—Betamethasone—hematologic cancer	0.000119	0.000154	CcSEcCtD
Gallamine Triethiodide—Pruritus—Dexamethasone—hematologic cancer	0.000119	0.000154	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—hematologic cancer	0.000119	0.000154	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000119	0.000154	CcSEcCtD
Gallamine Triethiodide—Vomiting—Triamcinolone—hematologic cancer	0.000118	0.000153	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—hematologic cancer	0.000117	0.000152	CcSEcCtD
Gallamine Triethiodide—Rash—Triamcinolone—hematologic cancer	0.000117	0.000152	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Triamcinolone—hematologic cancer	0.000117	0.000152	CcSEcCtD
Gallamine Triethiodide—Urticaria—Prednisone—hematologic cancer	0.000117	0.000151	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—hematologic cancer	0.000117	0.000151	CcSEcCtD
Gallamine Triethiodide—Headache—Triamcinolone—hematologic cancer	0.000116	0.000151	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Prednisone—hematologic cancer	0.000116	0.00015	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Prednisone—hematologic cancer	0.000116	0.00015	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—hematologic cancer	0.000116	0.00015	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Betamethasone—hematologic cancer	0.000115	0.000149	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dexamethasone—hematologic cancer	0.000115	0.000149	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—hematologic cancer	0.000114	0.000147	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—hematologic cancer	0.000112	0.000146	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—hematologic cancer	0.000112	0.000145	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	0.000112	0.000145	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—hematologic cancer	0.000112	0.000144	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—hematologic cancer	0.000111	0.000144	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—hematologic cancer	0.000111	0.000144	CcSEcCtD
Gallamine Triethiodide—Nausea—Triamcinolone—hematologic cancer	0.00011	0.000143	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—hematologic cancer	0.00011	0.000143	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.00011	0.000143	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Prednisone—hematologic cancer	0.000108	0.00014	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dexamethasone—hematologic cancer	0.000107	0.000139	CcSEcCtD
Gallamine Triethiodide—Vomiting—Betamethasone—hematologic cancer	0.000107	0.000139	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—hematologic cancer	0.000107	0.000139	CcSEcCtD
Gallamine Triethiodide—Rash—Dexamethasone—hematologic cancer	0.000106	0.000138	CcSEcCtD
Gallamine Triethiodide—Rash—Betamethasone—hematologic cancer	0.000106	0.000138	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Dexamethasone—hematologic cancer	0.000106	0.000138	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Betamethasone—hematologic cancer	0.000106	0.000138	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000106	0.000137	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—hematologic cancer	0.000106	0.000137	CcSEcCtD
Gallamine Triethiodide—Headache—Betamethasone—hematologic cancer	0.000106	0.000137	CcSEcCtD
Gallamine Triethiodide—Headache—Dexamethasone—hematologic cancer	0.000106	0.000137	CcSEcCtD
Gallamine Triethiodide—Asthenia—Prednisone—hematologic cancer	0.000105	0.000136	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—hematologic cancer	0.000105	0.000136	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	0.000105	0.000136	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000104	0.000135	CcSEcCtD
Gallamine Triethiodide—Pruritus—Prednisone—hematologic cancer	0.000104	0.000135	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—hematologic cancer	0.000104	0.000134	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—hematologic cancer	0.000103	0.000134	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—hematologic cancer	0.000103	0.000134	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—hematologic cancer	0.000101	0.000131	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Prednisone—hematologic cancer	0.000101	0.00013	CcSEcCtD
Gallamine Triethiodide—Nausea—Betamethasone—hematologic cancer	0.0001	0.00013	CcSEcCtD
Gallamine Triethiodide—Nausea—Dexamethasone—hematologic cancer	0.0001	0.00013	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.92e-05	0.000128	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—hematologic cancer	9.91e-05	0.000128	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—hematologic cancer	9.83e-05	0.000127	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—hematologic cancer	9.75e-05	0.000126	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—hematologic cancer	9.71e-05	0.000126	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—hematologic cancer	9.71e-05	0.000126	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.69e-05	0.000125	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—hematologic cancer	9.55e-05	0.000124	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—hematologic cancer	9.47e-05	0.000123	CcSEcCtD
Gallamine Triethiodide—Vomiting—Prednisone—hematologic cancer	9.34e-05	0.000121	CcSEcCtD
Gallamine Triethiodide—Rash—Prednisone—hematologic cancer	9.26e-05	0.00012	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Prednisone—hematologic cancer	9.25e-05	0.00012	CcSEcCtD
Gallamine Triethiodide—Headache—Prednisone—hematologic cancer	9.2e-05	0.000119	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.18e-05	0.000119	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—hematologic cancer	9.17e-05	0.000119	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—hematologic cancer	9.13e-05	0.000118	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—hematologic cancer	9.09e-05	0.000118	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—hematologic cancer	9.08e-05	0.000118	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—hematologic cancer	9.08e-05	0.000118	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—hematologic cancer	9.05e-05	0.000117	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methotrexate—hematologic cancer	8.81e-05	0.000114	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—hematologic cancer	8.76e-05	0.000113	CcSEcCtD
Gallamine Triethiodide—Nausea—Prednisone—hematologic cancer	8.73e-05	0.000113	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—hematologic cancer	8.69e-05	0.000112	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL13—hematologic cancer	8.58e-05	0.000675	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—LPAR1—hematologic cancer	8.5e-05	0.000669	CbGpPWpGaD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—hematologic cancer	8.47e-05	0.00011	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—hematologic cancer	8.45e-05	0.000109	CcSEcCtD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—hematologic cancer	8.44e-05	0.000664	CbGpPWpGaD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—hematologic cancer	8.4e-05	0.000109	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—hematologic cancer	8.4e-05	0.000109	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—hematologic cancer	8.4e-05	0.000109	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—IDH1—hematologic cancer	8.39e-05	0.00066	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.38e-05	0.000659	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL3RA—hematologic cancer	8.36e-05	0.000657	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.31e-05	0.000654	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTO1—hematologic cancer	8.29e-05	0.000652	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCC3—hematologic cancer	8.29e-05	0.000652	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TXN—hematologic cancer	8.29e-05	0.000652	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—EP300—hematologic cancer	8.25e-05	0.000649	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Epirubicin—hematologic cancer	8.24e-05	0.000107	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC11—hematologic cancer	8.2e-05	0.000645	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Epirubicin—hematologic cancer	8.13e-05	0.000105	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—SPHK1—hematologic cancer	8.12e-05	0.000638	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RGS2—hematologic cancer	8.06e-05	0.000634	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—hematologic cancer	8.01e-05	0.00063	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TRH—hematologic cancer	7.97e-05	0.000627	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—TRIO—hematologic cancer	7.97e-05	0.000627	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BCR—hematologic cancer	7.86e-05	0.000618	CbGpPWpGaD
Gallamine Triethiodide—Diarrhoea—Epirubicin—hematologic cancer	7.86e-05	0.000102	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—hematologic cancer	7.83e-05	0.000101	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CNR2—hematologic cancer	7.83e-05	0.000616	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PDE4B—hematologic cancer	7.83e-05	0.000616	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	7.81e-05	0.000614	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Methotrexate—hematologic cancer	7.81e-05	0.000101	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—UGT1A1—hematologic cancer	7.8e-05	0.000613	CbGpPWpGaD
Gallamine Triethiodide—Rash—Methotrexate—hematologic cancer	7.74e-05	0.0001	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—hematologic cancer	7.73e-05	0.0001	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—LPAR1—hematologic cancer	7.72e-05	0.000607	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RAC2—hematologic cancer	7.7e-05	0.000606	CbGpPWpGaD
Gallamine Triethiodide—Headache—Methotrexate—hematologic cancer	7.69e-05	9.96e-05	CcSEcCtD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—hematologic cancer	7.67e-05	0.000603	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.64e-05	0.000601	CbGpPWpGaD
Gallamine Triethiodide—Asthenia—Doxorubicin—hematologic cancer	7.63e-05	9.87e-05	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—SLC22A1—hematologic cancer	7.58e-05	0.000596	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CRABP1—hematologic cancer	7.58e-05	0.000596	CbGpPWpGaD
Gallamine Triethiodide—Pruritus—Doxorubicin—hematologic cancer	7.52e-05	9.74e-05	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—ALOX5—hematologic cancer	7.39e-05	0.000581	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.39e-05	0.000581	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADCY7—hematologic cancer	7.36e-05	0.000579	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC10—hematologic cancer	7.31e-05	0.000575	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Epirubicin—hematologic cancer	7.31e-05	9.46e-05	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—hematologic cancer	7.29e-05	9.44e-05	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—hematologic cancer	7.27e-05	9.42e-05	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—hematologic cancer	7.24e-05	9.38e-05	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—hematologic cancer	7.24e-05	9.37e-05	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—hematologic cancer	7.2e-05	9.32e-05	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—NUP98—hematologic cancer	7.16e-05	0.000563	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PDE4B—hematologic cancer	7.11e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR2—hematologic cancer	7.11e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAC2—hematologic cancer	6.99e-05	0.00055	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	6.97e-05	0.000548	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA3—hematologic cancer	6.95e-05	0.000547	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ADCY7—hematologic cancer	6.95e-05	0.000547	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NUP214—hematologic cancer	6.9e-05	0.000543	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—hematologic cancer	6.89e-05	0.000542	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.83e-05	0.000537	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Epirubicin—hematologic cancer	6.82e-05	8.83e-05	CcSEcCtD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.81e-05	0.000536	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTR—hematologic cancer	6.76e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG2—hematologic cancer	6.76e-05	0.000532	CbGpPWpGaD
Gallamine Triethiodide—Vomiting—Doxorubicin—hematologic cancer	6.76e-05	8.75e-05	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—hematologic cancer	6.7e-05	8.68e-05	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—hematologic cancer	6.7e-05	8.67e-05	CcSEcCtD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.7e-05	0.000527	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGEF12—hematologic cancer	6.69e-05	0.000526	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADCY7—hematologic cancer	6.68e-05	0.000526	CbGpPWpGaD
Gallamine Triethiodide—Headache—Doxorubicin—hematologic cancer	6.66e-05	8.62e-05	CcSEcCtD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—hematologic cancer	6.65e-05	0.000523	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO2—hematologic cancer	6.63e-05	0.000521	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGEF1—hematologic cancer	6.52e-05	0.000512	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTGER4—hematologic cancer	6.48e-05	0.000509	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—hematologic cancer	6.43e-05	0.000506	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.33e-05	0.000498	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—hematologic cancer	6.33e-05	0.000498	CbGpPWpGaD
Gallamine Triethiodide—Nausea—Doxorubicin—hematologic cancer	6.31e-05	8.17e-05	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism—SDC1—hematologic cancer	6.28e-05	0.000494	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.24e-05	0.000491	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL3—hematologic cancer	6.11e-05	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—hematologic cancer	6.04e-05	0.000475	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6e-05	0.000472	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.93e-05	0.000466	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTGER4—hematologic cancer	5.88e-05	0.000463	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGRN—hematologic cancer	5.84e-05	0.00046	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL17—hematologic cancer	5.84e-05	0.00046	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR5—hematologic cancer	5.74e-05	0.000451	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR4—hematologic cancer	5.72e-05	0.00045	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.67e-05	0.000446	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEF1—hematologic cancer	5.64e-05	0.000443	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GNA13—hematologic cancer	5.54e-05	0.000436	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL3—hematologic cancer	5.52e-05	0.000434	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CCL2—hematologic cancer	5.5e-05	0.000432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TIAM1—hematologic cancer	5.45e-05	0.000429	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.4e-05	0.000425	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NQO1—hematologic cancer	5.34e-05	0.00042	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD44—hematologic cancer	5.34e-05	0.00042	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RASGRP1—hematologic cancer	5.34e-05	0.00042	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CCL2—hematologic cancer	5.31e-05	0.000417	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAK3—hematologic cancer	5.29e-05	0.000416	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.23e-05	0.000412	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—hematologic cancer	5.22e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR4—hematologic cancer	5.2e-05	0.000409	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCR7—hematologic cancer	5.07e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL13—hematologic cancer	5.07e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYCS—hematologic cancer	5.06e-05	0.000398	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSP90AA1—hematologic cancer	5.02e-05	0.000395	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL3—hematologic cancer	5.01e-05	0.000394	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCOR2—hematologic cancer	5e-05	0.000393	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CRKL—hematologic cancer	4.94e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL3RA—hematologic cancer	4.94e-05	0.000388	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RASGRP1—hematologic cancer	4.85e-05	0.000381	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GRB2—hematologic cancer	4.8e-05	0.000377	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RGS2—hematologic cancer	4.76e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRIO—hematologic cancer	4.71e-05	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CMA1—hematologic cancer	4.71e-05	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TRH—hematologic cancer	4.71e-05	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGO2—hematologic cancer	4.61e-05	0.000363	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPHK1—hematologic cancer	4.61e-05	0.000363	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC9—hematologic cancer	4.56e-05	0.000359	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPAR1—hematologic cancer	4.56e-05	0.000359	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.52e-05	0.000356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—H3F3B—hematologic cancer	4.52e-05	0.000355	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—hematologic cancer	4.46e-05	0.000351	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GRB2—hematologic cancer	4.36e-05	0.000343	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.31e-05	0.000339	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CSF2—hematologic cancer	4.29e-05	0.000337	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—hematologic cancer	4.22e-05	0.000332	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR2—hematologic cancer	4.2e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE4B—hematologic cancer	4.2e-05	0.00033	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF19—hematologic cancer	4.16e-05	0.000327	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	4.14e-05	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	4.14e-05	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAC2—hematologic cancer	4.13e-05	0.000325	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DKK1—hematologic cancer	4.1e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—hematologic cancer	4.1e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOR1—hematologic cancer	4.1e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	4.07e-05	0.00032	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	3.95e-05	0.00031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	3.89e-05	0.000306	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	3.87e-05	0.000304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—XIAP—hematologic cancer	3.84e-05	0.000302	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	3.76e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	3.76e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	3.74e-05	0.000294	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	3.74e-05	0.000294	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GZMB—hematologic cancer	3.72e-05	0.000292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	3.63e-05	0.000286	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—hematologic cancer	3.62e-05	0.000285	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL3—hematologic cancer	3.61e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	3.61e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	3.61e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	3.57e-05	0.000281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SDC1—hematologic cancer	3.57e-05	0.000281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	3.51e-05	0.000276	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	3.48e-05	0.000273	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LCK—hematologic cancer	3.46e-05	0.000272	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	3.39e-05	0.000267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	3.29e-05	0.000259	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	3.22e-05	0.000253	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.19e-05	0.000251	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PARP1—hematologic cancer	3.18e-05	0.00025	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	3.13e-05	0.000246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	3.07e-05	0.000241	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	3.07e-05	0.000241	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—hematologic cancer	3.04e-05	0.000239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CBL—hematologic cancer	2.99e-05	0.000235	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL3—hematologic cancer	2.96e-05	0.000233	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	2.92e-05	0.00023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	2.91e-05	0.000229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	2.87e-05	0.000226	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	2.86e-05	0.000225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SYK—hematologic cancer	2.85e-05	0.000224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	2.85e-05	0.000224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.83e-05	0.000223	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CREBBP—hematologic cancer	2.82e-05	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	2.78e-05	0.000219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT1—hematologic cancer	2.75e-05	0.000216	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	2.72e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	2.72e-05	0.000214	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—hematologic cancer	2.67e-05	0.00021	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.67e-05	0.00021	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—hematologic cancer	2.64e-05	0.000208	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	2.6e-05	0.000204	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	2.59e-05	0.000204	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRB2—hematologic cancer	2.57e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	2.57e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	2.57e-05	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KITLG—hematologic cancer	2.53e-05	0.000199	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3R1—hematologic cancer	2.52e-05	0.000199	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	2.47e-05	0.000195	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	2.47e-05	0.000194	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	2.45e-05	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	2.43e-05	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD86—hematologic cancer	2.37e-05	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	2.36e-05	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HES1—hematologic cancer	2.34e-05	0.000184	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—hematologic cancer	2.33e-05	0.000183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	2.33e-05	0.000183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CSF2—hematologic cancer	2.3e-05	0.000181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF1—hematologic cancer	2.3e-05	0.000181	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	2.27e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	2.27e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	2.26e-05	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	2.24e-05	0.000176	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	2.23e-05	0.000175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	2.22e-05	0.000175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAK1—hematologic cancer	2.22e-05	0.000175	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	2.07e-05	0.000163	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—hematologic cancer	2.06e-05	0.000162	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—hematologic cancer	2.05e-05	0.000161	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—hematologic cancer	2.01e-05	0.000158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	2e-05	0.000157	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.96e-05	0.000154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—EP300—hematologic cancer	1.92e-05	0.000151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.88e-05	0.000148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.86e-05	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.83e-05	0.000144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.81e-05	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.78e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.78e-05	0.00014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.77e-05	0.000139	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.73e-05	0.000136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.73e-05	0.000136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.73e-05	0.000136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.73e-05	0.000136	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.7e-05	0.000133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.65e-05	0.00013	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.64e-05	0.000129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.62e-05	0.000128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.61e-05	0.000127	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.6e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.6e-05	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.53e-05	0.00012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.52e-05	0.000119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.5e-05	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.49e-05	0.000117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.45e-05	0.000114	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.43e-05	0.000113	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—hematologic cancer	1.42e-05	0.000112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.39e-05	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.37e-05	0.000107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.36e-05	0.000107	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.32e-05	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.32e-05	0.000104	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.26e-05	9.94e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.24e-05	9.77e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.23e-05	9.66e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.22e-05	9.57e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.22e-05	9.56e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.21e-05	9.51e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.19e-05	9.32e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.18e-05	9.3e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—hematologic cancer	1.16e-05	9.13e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.15e-05	9.02e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.14e-05	9e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.12e-05	8.8e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1.12e-05	8.78e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EP300—hematologic cancer	1.09e-05	8.58e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.06e-05	8.34e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.03e-05	8.13e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.02e-05	8.05e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.02e-05	8.03e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	9.77e-06	7.69e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—hematologic cancer	9.51e-06	7.48e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	9.48e-06	7.46e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—hematologic cancer	8.78e-06	6.91e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	8.07e-06	6.35e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—hematologic cancer	7.81e-06	6.14e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—hematologic cancer	7.47e-06	5.87e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—hematologic cancer	7.15e-06	5.62e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—hematologic cancer	6.59e-06	5.18e-05	CbGpPWpGaD
